Article

A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

2020-03-13

Abstract excerpt

<h4>Background</h4> Cancer cell phenotypes evolve over the course of a tumor’s treatment. The phenotypes that emerge and disappear over time will be specific to each drug regimen and type of cancer. Chemotherapy remains one of the most common and effective treatments for metastatic breast cancer patients; however, resistance to chemotherapy inevitably emerges. Cancer chemotherapy treatment regimens are not design...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b414bd96-04e0-5879-99a3-a540e2c823ff
DOI: 10.1101/2020.03.12.989251

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancerDOI 10.1101/2020.03.12.989251Read

Combating subclonal evolution of resistant cancer phenotypes.Semantic proximity Read

Clonal selection supported by single cell Dna sequencing reveals hormonal adaptation and resistance in locally advanced breast cancer During Neoadjuvant Aromatase InhibitionSemantic proximity Read

Treatment Resistance in Stem Cells and Breast CancerSemantic proximity Read

Chemotherapy reshapes cellular clonal landscape via persister programs in breast cancer xenograftsSemantic proximity Read

Single-Cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal Breast Cancer SubtypeSemantic proximity Read

Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification.Semantic proximity Read

A dormant sub-population expressing interleukin-1 receptor characterises anti-estrogen resistant ALDH+ breast cancer stem cellsSemantic proximity Read

A single-cell atlas of breast cancer cell lines to study tumour heterogeneity and drug responseSemantic proximity Read

Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast TumorsSemantic proximity Read

Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast CancerSemantic proximity Read

Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristicsSemantic proximity Read

An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapySemantic proximity Read